e-learning
resources
Vienna 2003
Sunday 28.09.2003
Clinical aspects of community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What is the value of multiple sputum cultures in the routine investigation of community acquired pneumonia (CAP)?
J. La Forge, N. Lampron, J. Plante (Sainte-Foy, Canada)
Source:
Annual Congress 2003 - Clinical aspects of community-acquired pneumonia
Session:
Clinical aspects of community-acquired pneumonia
Session type:
Thematic Poster Session
Number:
982
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. La Forge, N. Lampron, J. Plante (Sainte-Foy, Canada). What is the value of multiple sputum cultures in the routine investigation of community acquired pneumonia (CAP)?. Eur Respir J 2003; 22: Suppl. 45, 982
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Induced sputum (IS) analysis for bacterial pneumonia diagnosis in HIV positive patients
Source: Eur Respir J 2003; 22: Suppl. 45, 333s
Year: 2003
Factors related to obtain an etiological diagnosis in community acquired pneumonia (CAP)
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007
A prospective comparison of nursing home acquired pneumonia (NAP) with community acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 257s
Year: 2005
Value of routine microbial investigation in low-risk patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 420s
Year: 2002
Quality-indicators and prognostics in CAP in three populations
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
Biological markers in hospitalised patients with community acquired pneumonia (CAP)
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
Improving outcome in elderly patients with pneumonia
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005
Virusologic research in healthy persons of closed collectives
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
Biomarkers to discriminate bacterial, viral and mixed community acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
Relevance of correct antibiotic choice in community-acquired pneumonia (CAP)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005
Defining stability in pneumonia and the non-responding pneumonia
Source: Annual Congress 2005 - Outcome in severe pneumonia
Year: 2005
The results of bronchoscopy used in the examination and treatment of patients with community acquired pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 640s
Year: 2005
Progress of quality indicator rates regarding treatment of patients hospitalized in Germany due to community acquired pneumonia (CAP)
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
The general evaluation of community acquired pneumonia patients treated in our clinic
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004
Medical history and clinical profile of childhood community acquired pneumonia (CAP)
Source: Eur Respir J 2004; 24: Suppl. 48, 623s
Year: 2004
Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Applying sputum as a diagnostic tool in pneumonia - limited yield, minimal impact on treatment decisions
Source: Eur Respir J 2001; 18: Suppl. 33, 502s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept